Latest Information Update: 14 Nov 1994
Price : $50 *
At a glance
- Originator Janssen L.P.
- Class Cytostatics
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 14 Nov 1994 No-Development-Reported for Cancer in Belgium (Unknown route)